Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "Results From a Phase 1 Clinical Study of the All-Oral Regimen of CC-486 and Venetoclax for AML"

427 views
June 7, 2023
Comments 0
Login to view comments. Click here to Login